Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
C&F Financial | CFFI | May 31, 2024 | 43.94 | +0.32 |
C.H. Robinson Worldwide | CHRW | May 31, 2024 | 86.37 | +1.74 |
C3.ai | AI | May 31, 2024 | 29.57 | +3.50 |
C3is | CISS | May 31, 2024 | 1.80 | +9.76 |
C4 Therapeutics | CCCC | May 31, 2024 | 5.00 | +0.40 |
Cabaletta Bio | CABA | May 31, 2024 | 10.19 | +2.62 |
Cabana Target Drawdown 10 ETF | TDSC | May 31, 2024 | 24.12 | +0.97 |
Cabana Target Drawdown 7 ETF | TDSB | May 31, 2024 | 21.87 | +0.97 |
Cable One | CABO | May 31, 2024 | 385.91 | +2.75 |
Cabot | CBT | May 31, 2024 | 102.30 | +0.88 |
CACI International A | CACI | May 31, 2024 | 424.48 | +0.27 |
Cactus A | WHD | May 31, 2024 | 51.35 | +1.99 |
Cactus Acquisition 1 A | CCTS | May 31, 2024 | 11.45 | +0.44 |
Cadeler ADR | CDLR | May 31, 2024 | 25.04 | +2.12 |
Cadence Bank | CADE | May 31, 2024 | 28.55 | +1.03 |
Cadence Bank A | CADE-A | May 31, 2024 | 21.72 | +5.03 |
Cadence Design Systems | CDNS | May 31, 2024 | 286.31 | -0.67 |
Cadiz | CDZI | May 31, 2024 | 3.03 | 0.00 |
Cadiz Pref ADR | CDZIP | May 31, 2024 | 13.60 | +1.30 |
Cadre | CDRE | May 31, 2024 | 32.84 | +0.58 |
Cadrenal Therapeutics | CVKD | May 31, 2024 | 0.47 | +14.95 |
Cae | CAE | May 31, 2024 | 18.78 | +1.24 |
Caesars Entertainment | CZR | May 31, 2024 | 35.56 | +11.65 |
Caesarstone | CSTE | May 31, 2024 | 5.98 | +3.46 |
Cal-Maine Foods | CALM | May 31, 2024 | 61.67 | +2.58 |
Calamos Convertible High Fund | CHY | May 31, 2024 | 11.12 | +0.91 |
Calamos Convertible Opportunities And Income Fund | CHI | May 31, 2024 | 11.36 | +1.16 |
Calamos Dynamic Convertible & Income Fund | CCD | May 31, 2024 | 22.25 | +0.41 |
Calamos Global Dynamic Fund | CHW | May 31, 2024 | 6.66 | 0.00 |
Calamos Global Total Return Fund | CGO | May 31, 2024 | 10.51 | +1.11 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.